Nonpharmacologic Treatments for Attention-Deficit/Hyperactivity Disorder: A Systematic Review

被引:41
|
作者
Goode, Adam P. [4 ,5 ]
Coeytaux, Remy R. [7 ,8 ]
Maslow, Gary R. [1 ,2 ]
Davis, Naomi [1 ]
Hill, Sherika [1 ]
Namdari, Behrouz [1 ]
LaPointe, Nancy M. Allen [3 ,9 ]
Befus, Deanna [8 ]
Lallinger, Kathryn R. [5 ,10 ]
Bowen, Samantha E. [6 ]
Kosinski, Andrzej [5 ]
McBroom, Amanda J. [5 ,10 ]
Sanders, Gillian D. [5 ,10 ]
Kemper, Alex R. [11 ]
机构
[1] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA
[2] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA
[3] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[4] Duke Univ, Sch Med, Duke Orthopaed Surg, Durham, NC 27706 USA
[5] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
[6] Duke Univ, Sch Med, Duke Ctr Autism & Brain Dev, Durham, NC 27706 USA
[7] Wake Forest Univ, Sch Med, Dept Family & Community Med, Winston Salem, NC 27109 USA
[8] Wake Forest Univ, Sch Med, Ctr Integrat Med, Winston Salem, NC 27109 USA
[9] Premier Inc, Charlotte, NC USA
[10] Duke Evidence Based Practice Ctr, Durham, NC USA
[11] Nationwide Childrens Hosp, Div Ambulatory Pediat, 700 Childrens Dr,LAC5411, Columbus, OH 43205 USA
基金
美国医疗保健研究与质量局;
关键词
DEFICIT HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED TRIAL; FAMILY-SCHOOL INTERVENTION; RANDOMIZED CLINICAL-TRIAL; PROSPECTIVE FOLLOW-UP; OMEGA3; FATTY-ACIDS; DOUBLE-BLIND; YOUNG-CHILDREN; PSYCHOEDUCATION PROGRAM; GINKGO-BILOBA;
D O I
10.1542/peds.2018-0094
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
CONTEXT: Nonpharmacologic treatments for attention-deficit/hyperactivity disorder (ADHD) encompass a range of care approaches from structured behavioral interventions to complementary medicines. OBJECTIVES: To assess the comparative effectiveness of nonpharmacologic treatments for ADHD among individuals 17 years of age and younger. DATA SOURCES: PubMed, Embase, PsycINFO, and Cochrane Database of Systematic Reviews for relevant English-language studies published from January 1, 2009 through November 7, 2016. STUDY SELECTION: We included studies that compared any ADHD nonpharmacologic treatment strategy with placebo, pharmacologic, or another nonpharmacologic treatment. DATA EXTRACTION: Study design, patient characteristics, intervention approaches, follow-up times, and outcomes were abstracted. For comparisons with at least 3 similar studies, random-effects meta-analysis was used to generate pooled estimates. RESULTS: We identified 54 studies of nonpharmacologic treatments, including neurofeedback, cognitive training, cognitive behavioral therapy, child or parent training, dietary omega fatty acid supplementation, and herbal and/or dietary approaches. No new guidance was identified regarding the comparative effectiveness of nonpharmacologic treatments. Pooled results for omega fatty acids found no significant effects for parent rating of ADHD total symptoms (n = 411; standardized mean difference -0.32; 95% confidence interval -0.80 to 0.15; I-2 = 52.4%; P = .10) or teacher-rated total ADHD symptoms (n = 287; standardized mean difference -0.08; 95% confidence interval -0.47 to 0.32; I-2 = 0.0%; P = .56). LIMITATIONS: Studies often did not reflect the primary care setting and had short follow-up periods, small sample sizes, variations in outcomes, and inconsistent reporting of comparative statistical analyses. CONCLUSIONS: Despite wide use, there are significant gaps in knowledge regarding the effectiveness of ADHD nonpharmacologic treatments.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Parental perspectives on attention-deficit/hyperactivity disorder treatments for children
    Vitulano, Lawrence A.
    Mitchell, John T.
    Vitulano, Michael L.
    Leckman, James F.
    Saunders, David
    Davis, Naomi
    Woodward, Diana
    Goodhue, Bethany
    Artukoglu, Bekir
    Kober, Hedy
    CLINICAL CHILD PSYCHOLOGY AND PSYCHIATRY, 2022, 27 (04) : 1019 - 1032
  • [42] Reading Interventions for Students With or At Risk of Attention-Deficit/Hyperactivity Disorder: A Systematic Review
    Stewart, Alicia A.
    Austin, Christy R.
    REMEDIAL AND SPECIAL EDUCATION, 2020, 41 (06) : 352 - 367
  • [43] Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder A Systematic Literature Review
    Wu, Eric Q.
    Hodgkins, Paul
    Ben-Hamadi, Rym
    Setyawan, Juliana
    Xie, Jipan
    Sikirica, Vanja
    Du, Ella X.
    Yan, Sherry Y.
    Erder, M. Haim
    CNS DRUGS, 2012, 26 (07) : 581 - 600
  • [44] Systematic Review: Educational Accommodations for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
    Lovett, Benjamin J.
    Nelson, Jason M.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (04) : 448 - 457
  • [45] Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review
    Schmitt, J.
    Buske-Kirschbaum, A.
    Roessner, V.
    ALLERGY, 2010, 65 (12) : 1506 - 1524
  • [46] A systematic review of attention-deficit/hyperactivity disorder in people living with cystic fibrosis
    Power, Hilary
    Shivak, Shelby
    Kim, Jinsoo
    Wright, Kristi
    PEDIATRIC PULMONOLOGY, 2024, 59 (04) : 825 - 833
  • [47] Stress as a mediator of brain alterations in attention-deficit hyperactivity disorder: A systematic review
    Koppelmaa, Kristin
    Ohki, Cristine Marie Yde
    Walter, Natalie Monet
    Walitza, Susanne
    Grunblatt, Edna
    COMPREHENSIVE PSYCHIATRY, 2024, 130
  • [48] Raynaud Syndrome Associated with Medication for Attention-Deficit/Hyperactivity Disorder: A Systematic Review
    Besag, Frank M. C.
    Vasey, Michael J.
    Roy, Sulagna
    Cortese, Samuele
    CNS DRUGS, 2025, 39 (03) : 213 - 241
  • [49] Prevalence of Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis
    Thomas, Rae
    Sanders, Sharon
    Doust, Jenny
    Beller, Elaine
    Glasziou, Paul
    PEDIATRICS, 2015, 135 (04) : E994 - E1001
  • [50] Adult Attention-Deficit/Hyperactivity Disorder: a Narrative Review of Biological Mechanisms, Treatments, and Outcomes
    Pagan, Antonio F.
    Huizar, Yazmine P.
    Short, Tucker R.
    Gotcher, Zoe
    Schmidt, Adam T.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2023, 23 (08) : 451 - 460